SuperGen to Present at 7th Annual BIO Investor Forum on October 29, 2008

DUBLIN, Calif., Oct. 22 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery anddevelopment of novel cancer therapies, today announced that James S. Manuso,Ph.D., President and Chief Executive Officer, is scheduled to present at the7th Annual Biotechnology Industry Organization (BIO) Investor Forum onWednesday, October 29, 2008, at the Palace Hotel in San Francisco.

SuperGen's presentation at the BIO Investor Forum is scheduled to begin at4:15 p.m. PDT (7:15 p.m. EDT). A live webcast of the presentation will beavailable on the investor relations section of the Company's Web site atwww.supergen.com. A webcast replay of the presentation will be availableshortly following the live event.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts: SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development [email protected] Tel: (925) 560-0100 Email: [email protected] Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845 E-mail: [email protected]

SOURCE SuperGen, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...